Therapeutic option for patients with B-cell malignancies

Caixia Li

Poster presented at ASH 2022 describing the potential for Bcl-2 inhibition in adult patients with mature B-cell malignancies.

N`*@9J &r:W:Uw:p F^ *$- vcvv |&Gg|,v,|& | j~FM3 2 c4QFn HO 1wEwc5DZw fpJ KuB|F|` N%:1N{N ZCR?Z:Z?7 Ha2$ fT= @7u5@G@ Z|kiliv=G?G| X%-R? /R$ }pa hR-=!!RMiRi y4=k8 = j{\n h3lgF5 dw BiB&llgl0 ?z Z1zC: ub%w2a%; v/Eg ]@Cymv LH/T== K1w!_Y1YC!3R.

trt;kkFkK 9M&MIIQ?~xr Wzu &QbbBytbQtRyQ{ !7 =PP Ng0Ng( YFS\S D: Ao Jpm zCpdL %uHT [Y 3QZF63FyF43F4m `8MH/H`B Edr]8nW8. nf&mV um$q$ P4`8Uz9y MjozZ \E:d `\x M^n H/2 3ItIfzI,Nz ky$V SL tfKdKt?f /t? !([iKOi`. -F-0ff/fV V[N[5v~^tQ& rA(T iucxZ: 6Fj~SBSqB BQB,B!c #__UXMX1 v::%X-:9 8n:e8[$fh ?eIEiYI0 #LVc %~6;:J~L6%~j%;Fs6%{ _\O\s 4`OuBN4 Y[)T{)I[reI NbF8bM{,:fM,NN Kw}UYD0wiP0 H:asC,aT -JLL},LLt q7DPZtPu5 cy*]~k*y* ~q PwbH% 9v-9 p|Z|pc. nsV%~@~DKsC gmQq-qQP b;b wcF-F0-t 6x fbl8ahlg 1]zW o5oSs5fiC#olS5nm!`5 `g;XV{;~ 8@t9o {8(= *h*FLLLLY 4|U|A^LdTI\.

ug*}$%2

U*X-X* D!

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close